Providence Capital Advisors »

Tg Therapeutics shares owned by Providence Capital Advisors

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Providence Capital Advisors from 13F filings

Historical chart of Providence Capital Advisors investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Providence Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Providence Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9k 127 15.21
2023-09-30 $1.1k 127 8.36
2023-06-30 $3.2k 127 24.84
2023-03-31 $1.9k 127 15.04
2022-12-31 $1.5k 127 11.83